See more : Ashoka WhiteOak Emerging Markets Ord (AWEM.L) Income Statement Analysis – Financial Results
Complete financial analysis of Innospec Inc. (IOSP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Innospec Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Resolute Forest Products Inc. (0KW8.L) Income Statement Analysis – Financial Results
- Hunan Goke Microelectronics Co.,Ltd. (300672.SZ) Income Statement Analysis – Financial Results
- Tapaco Public Company Limited (TAPAC.BK) Income Statement Analysis – Financial Results
- Rushil Décor Limited (RUSHIL.BO) Income Statement Analysis – Financial Results
- Rhythm Pharmaceuticals, Inc. (RYTM) Income Statement Analysis – Financial Results
Innospec Inc. (IOSP)
About Innospec Inc.
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.95B | 1.96B | 1.48B | 1.19B | 1.51B | 1.48B | 1.31B | 883.40M | 1.01B | 960.90M | 818.80M | 776.40M | 774.40M | 683.20M | 598.50M | 640.50M | 602.40M | 532.10M | 527.70M | 480.50M | 462.20M | 451.50M | 420.90M | 422.40M | 516.80M | 465.00M |
| Cost of Revenue | 1.36B | 1.38B | 1.05B | 850.40M | 1.05B | 1.04B | 903.50M | 551.10M | 666.30M | 658.90M | 563.60M | 540.00M | 548.00M | 466.00M | 409.20M | 454.10M | 405.00M | 345.40M | 338.20M | 271.00M | 257.70M | 257.30M | 240.20M | 238.90M | 309.90M | 227.20M |
| Gross Profit | 591.10M | 586.70M | 434.90M | 342.70M | 466.20M | 435.00M | 403.30M | 332.30M | 346.00M | 302.00M | 255.20M | 236.40M | 226.40M | 217.20M | 189.30M | 186.40M | 197.40M | 186.70M | 189.50M | 209.50M | 204.50M | 194.20M | 180.70M | 183.50M | 206.90M | 237.80M |
| Gross Profit Ratio | 30.33% | 29.88% | 29.32% | 28.72% | 30.81% | 29.45% | 30.86% | 37.62% | 34.18% | 31.43% | 31.17% | 30.45% | 29.24% | 31.79% | 31.63% | 29.10% | 32.77% | 35.09% | 35.91% | 43.60% | 44.24% | 43.01% | 42.93% | 43.44% | 40.03% | 51.14% |
| Research & Development | 41.70M | 38.70M | 37.40M | 30.90M | 35.40M | 33.40M | 31.40M | 25.40M | 25.30M | 22.20M | 21.20M | 19.60M | 18.30M | 17.60M | 16.40M | 14.80M | 13.60M | 11.10M | 11.20M | 10.50M | 5.10M | 6.00M | 5.10M | 3.10M | 3.90M | 3.10M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 387.80M | 360.70M | 267.20M | 237.00M | 280.90M | 261.00M | 239.50M | 209.50M | 206.70M | 169.20M | 141.90M | 117.10M | 155.90M | 111.90M | 142.50M | 115.20M | 103.90M | 99.00M | 97.60M | 93.40M | 75.70M | 70.00M | 57.60M | 41.50M | 44.90M | 40.10M |
| Other Expenses | 0.00 | -1.60M | 3.80M | 7.80M | 5.30M | 5.00M | 6.60M | 900.00K | 0.00 | 1.80M | 4.10M | -2.00M | 0.00 | 4.60M | 4.70M | 7.00M | 29.00M | 40.20M | 147.10M | 56.30M | 10.40M | -6.30M | -103.93M | 80.20M | 68.40M | 59.70M |
| Operating Expenses | 429.50M | 399.40M | 304.60M | 267.90M | 316.30M | 294.40M | 270.90M | 234.90M | 232.00M | 191.40M | 163.10M | 136.70M | 174.20M | 134.10M | 163.60M | 137.00M | 146.50M | 150.30M | 255.90M | 160.20M | 91.20M | 69.70M | -41.23M | 124.80M | 117.20M | 102.90M |
| Cost & Expenses | 1.79B | 1.78B | 1.35B | 1.12B | 1.36B | 1.34B | 1.17B | 786.00M | 898.30M | 850.30M | 726.70M | 676.70M | 722.20M | 600.10M | 572.80M | 591.10M | 551.50M | 495.70M | 594.10M | 431.20M | 348.90M | 327.00M | 198.97M | 363.70M | 427.10M | 330.10M |
| Interest Income | 2.30M | 1.10M | 1.50M | 1.80M | 4.80M | 0.00 | 0.00 | 0.00 | 0.00 | 400.00K | 400.00K | 600.00K | 600.00K | 500.00K | 300.00K | 1.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 1.10M | 1.50M | 1.80M | 4.80M | 6.90M | 8.20M | 3.20M | 4.00M | 3.40M | 2.30M | 1.80M | 3.30M | 4.60M | 6.00M | 6.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 39.30M | 45.00M | 46.20M | 50.70M | 51.00M | 55.70M | 55.60M | 37.70M | 35.20M | 29.10M | 20.40M | 11.50M | 14.40M | 15.40M | 18.40M | 23.00M | 31.30M | 27.40M | 28.70M | 24.40M | 25.80M | 32.40M | 87.20M | 80.20M | 68.40M | 59.70M |
| EBITDA | 200.90M | 187.30M | 182.10M | 92.20M | 206.20M | 194.20M | 191.90M | 144.00M | 156.30M | 143.40M | 115.10M | 109.80M | 66.60M | 90.00M | 43.00M | 47.80M | 88.60M | 71.40M | -79.70M | 130.40M | 138.60M | 156.90M | 309.13M | 138.90M | 158.10M | 194.70M |
| EBITDA Ratio | 10.31% | 11.50% | 11.92% | 10.78% | 13.40% | 13.22% | 14.49% | 15.44% | 14.74% | 14.73% | 14.29% | 14.14% | 8.60% | 14.42% | 7.37% | 15.22% | 15.01% | 16.73% | 26.64% | 27.14% | 34.29% | 39.03% | 73.66% | 32.55% | 28.75% | 41.38% |
| Operating Income | 161.60M | 187.30M | 132.10M | 82.60M | 149.90M | 133.50M | 129.70M | 105.40M | 156.30M | 112.50M | 90.60M | 98.40M | 49.60M | 72.20M | 20.70M | 43.60M | 47.90M | 31.90M | -97.70M | 40.80M | 98.30M | 105.00M | 59.30M | 58.70M | 89.70M | 134.90M |
| Operating Income Ratio | 8.29% | 9.54% | 8.91% | 6.92% | 9.91% | 9.04% | 9.93% | 11.93% | 15.44% | 11.71% | 11.06% | 12.67% | 6.40% | 10.57% | 3.46% | 6.81% | 7.95% | 6.00% | -18.51% | 8.49% | 21.27% | 23.26% | 14.09% | 13.90% | 17.36% | 29.01% |
| Total Other Income/Expenses | 12.80M | -2.70M | 2.30M | -35.10M | 500.00K | -1.90M | -4.30M | -2.30M | -4.00M | -1.60M | 2.20M | -3.20M | 3.00M | -1.50M | -2.40M | -24.70M | -200.00K | 0.00 | -20.40M | -7.70M | -20.60M | -31.00M | -22.60M | -23.00M | -14.40M | -23.10M |
| Income Before Tax | 174.40M | 184.60M | 134.40M | 39.70M | 150.40M | 131.60M | 128.10M | 103.10M | 152.30M | 110.90M | 92.80M | 95.20M | 52.60M | 70.70M | 18.30M | 18.80M | 47.70M | 31.90M | -118.10M | 31.10M | 77.10M | 74.00M | 36.70M | 35.70M | 75.30M | 111.90M |
| Income Before Tax Ratio | 8.95% | 9.40% | 9.06% | 3.33% | 9.94% | 8.91% | 9.80% | 11.67% | 15.04% | 11.54% | 11.33% | 12.26% | 6.79% | 10.35% | 3.06% | 2.94% | 7.92% | 6.00% | -22.38% | 6.47% | 16.68% | 16.39% | 8.72% | 8.45% | 14.57% | 24.06% |
| Income Tax Expense | 35.30M | 51.60M | 41.30M | 11.00M | 38.20M | 46.60M | 66.30M | 21.80M | 32.80M | 26.80M | 15.00M | 26.90M | 3.70M | -3.00M | 11.90M | 6.30M | 18.20M | 20.40M | 4.20M | 20.00M | 23.30M | 23.00M | 19.80M | 17.40M | 32.70M | 41.50M |
| Net Income | 139.10M | 133.00M | 93.10M | 28.70M | 112.20M | 85.00M | 61.80M | 81.30M | 119.50M | 84.10M | 77.80M | 68.30M | 48.90M | 73.70M | 6.40M | 12.50M | 29.50M | 11.40M | -123.70M | 6.20M | 51.80M | 52.10M | 5.60M | 18.30M | 42.60M | 70.40M |
| Net Income Ratio | 7.14% | 6.77% | 6.28% | 2.41% | 7.41% | 5.76% | 4.73% | 9.20% | 11.80% | 8.75% | 9.50% | 8.80% | 6.31% | 10.79% | 1.07% | 1.95% | 4.90% | 2.14% | -23.44% | 1.29% | 11.21% | 11.54% | 1.33% | 4.33% | 8.24% | 15.14% |
| EPS | 5.60 | 5.37 | 3.78 | 1.17 | 4.58 | 3.48 | 2.56 | 3.39 | 4.96 | 3.45 | 3.29 | 2.89 | 2.07 | 3.10 | 0.27 | 0.53 | 1.23 | 0.47 | -5.00 | 0.25 | 2.17 | 2.21 | 0.24 | 0.73 | 1.54 | 2.42 |
| EPS Diluted | 5.56 | 5.32 | 3.75 | 1.16 | 4.54 | 3.45 | 2.52 | 3.33 | 4.86 | 3.38 | 3.22 | 2.81 | 1.99 | 2.97 | 0.26 | 0.51 | 1.19 | 0.45 | -5.00 | 0.24 | 2.06 | 2.08 | 0.23 | 0.71 | 1.53 | 2.42 |
| Weighted Avg Shares Out | 24.85M | 24.79M | 24.65M | 24.56M | 24.48M | 24.40M | 24.15M | 24.00M | 24.11M | 24.39M | 23.65M | 23.19M | 24.52M | 23.76M | 23.64M | 23.60M | 23.92M | 24.14M | 24.74M | 24.69M | 23.87M | 23.63M | 23.53M | 25.16M | 27.65M | 29.03M |
| Weighted Avg Shares Out (Dil) | 25.02M | 24.98M | 24.85M | 24.78M | 24.73M | 24.60M | 24.49M | 24.44M | 24.61M | 24.88M | 24.16M | 23.85M | 24.57M | 24.81M | 24.71M | 24.39M | 24.84M | 25.34M | 24.74M | 25.98M | 25.15M | 25.11M | 24.89M | 26.00M | 27.96M | 29.03M |
Innospec Reports First Quarter 2024 Financial Results
Strong contribution from Performance Chemicals drives operating income growth of 23 percent $80.6 million cash generated from operations; Net cash improves to $270.1 million Dividend increased by 10 percent; Strong debt-free balance sheet GAAP EPS of $1.65 and adjusted non-GAAP...
Innospec (IOSP) Reports Next Week: Wall Street Expects Earnings Growth
Innospec (IOSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Diversified Chemical Stocks to Gain From Demand Rebound
The Zacks Chemicals Diversified industry is expected to benefit from an uptick in demand across major end-use markets and the moderation of de-stocking activities. EMN, AVNT, IOSP and KRO are set to gain from strategic actions and demand recovery.
Why Innospec (IOSP) is Poised to Beat Earnings Estimates Again
Innospec (IOSP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Innospec Schedules First Quarter 2024 Earnings Release and Conference Call
ENGLEWOOD, Colo., April 05, 2024 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release first quarter 2024 earnings results on Thursday, May 9, 2024 after market close.
Innospec (IOSP) Shares Rally 25% in 6 Months: What's Driving It?
Innospec (IOSP) drives growth through strong earnings, strategic acquisitions like QGP in Brazil and investment in technology and capacity expansion amid optimism for 2024.
Are Basic Materials Stocks Lagging Innospec (IOSP) This Year?
Here is how Innospec (IOSP) and Kronos Worldwide (KRO) have performed compared to their sector so far this year.
Innospec Inc. (IOSP) Hit a 52 Week High, Can the Run Continue?
Innospec (IOSP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Innospec (IOSP) Hits 52-Week High: What's Driving the Stock?
Innospec (IOSP) shows strong growth potential, driven by its Oilfield Services unit, strategic acquisitions like QGP Quimica Geral and consistent earnings outperformance.
3 Top Chemical Stocks to Scoop Up on a Demand Rebound
A rebound in end-market demand, moderating raw material and energy costs and the absence of customer inventory destocking augur well for the chemical industry. HWKN, IOSP and KRO are worth a look.
Source: https://incomestatements.info
Category: Stock Reports